Enpicom ImmunoGenomiX Platform With Antibody Discovery Mode
Netherlands-based Enpicom has released its ImmunoGenomiX (IGX) bioinformatics platform with an antibody discovery module. The IGX platform is designed to manage, analyze, integrate, and visualize immune repertoire sequencing data in a single environment. It is technology-agnostic and code-free, and enables scientists to securely analyze immune repertoires, the company said. The new antibody discovery module applications are IGX-Cluster and IGX-Branch. IGX-Cluster groups sequences based on user-defined parameters such as CDR3 similarity, gene usage, and CDR3 length. It performs large clustering tasks in the cloud and supports a wide variety of workflows for both paired and unpaired receptor chains. Subsequently, IGX-Branch creates interactive visualizations to prioritize clusters and pick antibody candidates for follow-up analysis through information-rich phylogenetic trees.